Pneumonia Vaccine Market Size, Share, Growth, Trends, Forecast 2022-2030 || Research Report - PowerPoint PPT Presentation

About This Presentation
Title:

Pneumonia Vaccine Market Size, Share, Growth, Trends, Forecast 2022-2030 || Research Report

Description:

Stay up-to-date with latest Insights of Pneumonia Vaccine market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth. Get More Info@ – PowerPoint PPT presentation

Number of Views:18

less

Transcript and Presenter's Notes

Title: Pneumonia Vaccine Market Size, Share, Growth, Trends, Forecast 2022-2030 || Research Report


1
(No Transcript)
2
What is Pneumonia Vaccine?
  • Pneumonia is a lung infection that occurs in one
    or both the lungs caused by bacteria, virus, or
    fungi however, bacterial pneumonia is the most
    common form occurring in adults. Pneumonia
    results in inflammation in the air sacs (known as
    alveoli) of the lungs, which results in filling
    the alveoli with fluid (pus cells), thus causing
    breathing problems. Pneumococcal disease is
    common in young children, but older adults are at
    greatest risk of serious pneumococcal infections
    and even death. Pneumonia vaccines are primarily
    administered to children less than 2-years old
    and adults aged 65 years and older. This vaccine
    helps individuals provide immunization against 13
    types of pneumococcal bacteria that causes
    infection in the lungs.

3
Pneumonia Vaccine Market Global Major Players
  • Glaxosmithkline plc., LG Chem Ltd., Merck Co.,
    Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax
    Incorporated, Serum Institute of India Pvt. Ltd.,
    Shenzhen Kangtai Biological Products Co., Ltd.
    (Beijing Minhai Biotechnology Corporation
    Limited), SK Bioscience and Walvax Biotechnology
    Co., Ltd.

4
Pneumonia Vaccine Market Segmentation
  • by Vaccine Type Pneumococcal Conjugate Vaccine,
    Pneumococcal Polysaccharide Vaccine
  • by Product Type Prevnar 13, Synflorix, Pneumovax
    23
  • by Sector Public, Private
  • by Distribution Channel Distribution Partner
    Companies, Non-governmental Organizations (NGO),
    Government Authorities

5
Pneumonia Vaccine Market Regional Outlook
  • The market is evaluated based on its regional
    penetration, explaining the performance of the
    market in each regional market covering regions
    such as North America (United States, Canada and
    Mexico), Europe (Germany, France, UK, Russia and
    Italy), Asia-Pacific (China, Japan, Korea, India
    and Southeast Asia), South America (Brazil,
    Argentina, Colombia), Middle East and Africa
    (Saudi Arabia, UAE, Egypt, Nigeria and South
    Africa)
  • Get Sample PDF Heregtgtgt https//www.alliedmarketres
    earch.com/request-sample/2730

6
About Us
  • Allied Market Research (AMR) is a market research
    and business-consulting firm of Allied Analytics
    LLP, based in Portland, Oregon. AMR offers market
    research reports, business solutions, consulting
    services, and insights on markets across 11
    industry verticals. Adopting extensive research
    methodologies, AMR is instrumental in helping its
    clients to make strategic business decisions and
    achieve sustainable growth in their market
    domains. We are equipped with skilled analysts
    and experts, and have a wide experience of
    working with many Fortune 500 companies and small
    medium enterprises.
  • Visit Our Website_at_ https//www.alliedmarketresearc
    h.com

7
Contact Us
  • David Correa
  • 5933 NE Win Sivers Drive
  • 205, Portland, OR 97220
  • United States
  • USA/Canada (Toll Free) 1-800-792-5285,
    1-503-894-6022, 1-503-446-1141
  • UK 44-845-528-1300
  • Hong Kong 852-301-84916
  • India (Pune) 91-20-66346060
Write a Comment
User Comments (0)
About PowerShow.com